Drug intelligence / Profile preview

5-phenylsulfanyl-2,4-quinazolinediamine

Development stage
Unknown
Modality
Small Molecules
01

Overview

A synthetic small molecule with the chemical formula C14H12N4S and a molecular weight of approximately 268.34 g/mol. It is an experimental compound that has been studied primarily as an inhibitor of dihydrofolate reductase (DHFR), a key enzyme in folate metabolism essential for de novo glycine and purine synthesis and DNA precursor synthesis. The drug has not been approved for any indication and is not known to be in active clinical development or marketed anywhere[1][2][6]. Its primary mechanism involves targeting DHFR; however, it may also interact with other related enzymes based on protein binding data[1][6].

Other names
5-(phenylsulfanyl)quinazoline-2,4-diamine5-PHENYLSULFANYLQUINAZOLINE-2,4-DIAMINE5-PHENYLSULFANYL-2,4-QUINAZOLINEDIAMINE5-(Phenylsulfanyl)-2,4-chinazolindiamin5-(Phénylsulfanyl)-2,4-quinazolinediamine5-thiophenylquinazoline diamine
02

Targets

DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on 5-phenylsulfanyl-2,4-quinazolinediamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-phenylsulfanyl-2,4-quinazolinediamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call